Anti-Mouse CD19 PE-Cy5 (Discontinued. Alternative clone Cat. No. 15-0193)

Also known as: AW495831

Clone: MB19-1

RUO: For Research Use Only. Not for use in diagnostic procedures.

Attention: Alternative clone 1D3 is available. Refer to Cat. No. 15-0193

SKU# 15-0191

Cat. No. Size
This product is not available in your region.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Anti-Mouse CD19 PE-Cy5.

Staining of C57Bl/6 splenocytes with Anti-Mouse CD3e (cat.12-0031) (left) or with 0.125 ug...View More

  • Data for Anti-Mouse CD19 PE-Cy5.
Description

Description: The MB19-1 monoclonal antibody reacts with mouse CD19, a 95 kDa transmembrane glycoprotein. CD19 is expressed by B cells during all stages of development excluding the terminally differentiated plasma cells. Follicular dendritic cells also express CD19. Together CD21, CD81, MHC class II, and CD19 form a multimolecular complex that associates with the BCR. Signaling through CD19 induces tyrosine phosphorylation, calcium flux and proliferation of B cells. Staining of B cells with MB19-1 and its conjugates is usually dimmer than the rat anti-mouse CD19 antibody, clone 6D5.

Details
Host Mouse
Isotype IgA, kappa
Reactivity Mouse
Laser Blue Laser, Green Laser, Yellow-Green Laser
Excite 488 - 561 nm
Legal FOR NON-COMMERCIAL RESEARCH USE ONLY. NOT FOR THERAPEUTIC OR IN VIVO APPLICATIONS. OTHER USE NEEDS LICENSE FROM GE HEALTHCARE BIO-SCIENCES CORP. UNDER U.S. PATENT FOR NON-COMMERCIAL RESEARCH USE ONLY. NOT FOR THERAPEUTIC OR IN VIVO APPLICATIONS. OTHER USE NEEDS LICENSE FROM GE HEALTHCARE BIO-SCIENCES CORP. UNDER U.S. PATENT # 5,268,486, 5,569,587 AND 5,627,027 AND FOREIGN EQUIVALENTS AND PENDING APPLICATIONS. THIS MATERIAL IS SUBJECT TO PROPRIETARY RIGHTS OF GE HEALTHCARE BIO-SCIENCES CORP. AND CARNEGIE MELLON UNIVERSITY AND MADE AND SOLD UNDER LICENSE FROM GE HEALTHCARE BIO-SCIENCES CORP. THIS PRODUCT IS LICENSED FOR SALE ONLY FOR RESEARCH. IT IS NOT LICENSED FOR ANY OTHER USE. THERE IS NO IMPLIED LICENSE HEREUNDER FOR ANY COMMERCIAL USE. COMMERCIAL USE shall include: 1. sale, lease, license or other transfer of the material or any material derived or produced from it; 2. sale, lease, license or other grant of rights to use this Material or any material derived or produced from it; 3. use of this material to perform services for a fee for third parties. IF YOU REQUIRE A COMMERCIAL LICENSE TO USE THIS MATERIAL AND DO NOT HAVE ONE, RETURN THIS MATERIAL, UNOPENED TO EBIOSCIENCE, INC. 10255 SCIENCE CENTER DRIVE, SAN DIEGO, CALIFORNIA 92121 USA AND ANY MONEY PAID FOR THE MATERIAL WILL BE REFUNDED.
Reported Applications Flow Cytometric Analysis
Documentation
TDS Link Download TDS
Additional Formats
Cat. No. Name Excite Emit Application Reg.
36-0191 Anti-Mouse CD19 Functional Grade Biotin FC, FA, IP RUO
11-0191 Anti-Mouse CD19 FITC 488 nm FC RUO
13-0191 Anti-Mouse CD19 Biotin FC RUO
16-0191 Anti-Mouse CD19 Functional Grade Purified FC, FA, IP RUO
14-0191 Anti-Mouse CD19 Purified FC, FA, IP RUO
17-0191 Anti-Mouse CD19 APC 633 - 647 nm 660 nm FC RUO
12-0191 Anti-Mouse CD19 PE 488 - 561 nm 575 nm FC RUO
Related Products
Cat. No. Name Excite Emit Application Reg.
12-0031 Anti-Mouse CD3e PE 488 - 561 nm 575 nm FC RUO
References

References: Engel, P., L. J. Zhou, et al. (1995).Immunity 3(1): 39-50.
Sato, S., N. Ono, et al. (1996). "CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity." J Immunol 157(10): 4371-8.
Sato, S., D. A. Steeber, et al. (1997). "CD19 expression levels regulate B lymphocyte development: human CD19 restores normal function in mice lacking endogenous CD19." J Immunol 158(10): 4662-9.
Tedder, T. F., M. Inaoki, et al. (1997). "The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity." Immunity 6(2): 107-18.


View More Products

AntigensArea of BiologyCell TypeFormats